Prochlorperazine and chlorpromazine: a comparative clinical trial.

Prochlorperazine and chlorpromazine: a comparative clinical trial. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Prochlorperazine and chlorpromazine: a comparative clinical trial. Abstract Text:

P SUNDBY,J B LIEN,

Prochlorperazine and chlorpromazine: a comparative clinical trial. Publishing Authors By Initials

P SUNDBY,JB LIEN,

For similar mental disorders: schizophrenia and disorders with psychotic features: psychotic disorders research abstracts see: mental disorders: schizophrenia and disorders with psychotic features: psychotic disorders research

PUBMED ID PMID:

MEDLINE DATE:

Prochlorperazine and chlorpromazine: a comparative clinical trial. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Acta psychiatrica Scandinavica. Supplementum

VOLUME: 34

Page Numbers: 82-8

Journal Abbreviation:

ISSN: 0065-1591

DAY: 15

MONTH: 02

YEAR: 1959

Prochlorperazine and chlorpromazine: a comparative clinical trial. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370365

Prochlorperazine and chlorpromazine: a comparative clinical trial. Keywords Mesh Terms:

KEYWORDS: Psychotic Disorders

MESH TERMS: therapy

Chemical & Substance for Abstract: Prochlorperazine and chlorpromazine: a comparative clinical trial. Information

Substance Name: Prochlorperazine

Registry Number: 58-38-8

Grant and Affiliation Information for Prochlorperazine and chlorpromazine: a comparative clinical trial.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Acta Psychiatr Scand Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Prochlorperazine and chlorpromazine: a comparative clinical trial Related Publications

• Analysis of the quantitative structure activity relationship of technetium-99m-labeled diaminedithiol (DADT) and propylene-amine-oxime (PAO) brain blood flow analogues.
• Assessment of space radiation effects on solid-state Brillouin phase conjugate mirrors.
• Caco-2 cell permeability vs human gastrointestinal absorption: QSPR analysis.
• Carcinogenicity, mutagenicity and cancer preventing activities of flavonoids: a structure-system-activity relationship (SSAR) analysis.
• Chimeric RNA/DNA oligonucleotide-based gene therapy.
• Construction of a dense SNP map for bovine chromosome 6 to assist the assembly of the bovine genome sequence.
• Design and discovery of new drugs by stepping-up and stepping-down approaches.
• Development of HIV protease inhibitors: a survey.
• Development of HIV protease inhibitors: a survey.
• Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism.
• Effects of furosemide on renal calcium handling.
• Fungal metabolites and Chinese herbal medicine as immunostimulants.
• Glucosamine and chondroitin sulfates in the treatment of osteoarthritis: a survey.
• Immunopharmacological and biochemical bases of Chinese herbal medicine.
• In search of ideal antihypertensive drugs: progress in five decades.
• Incidence of radiation-induced insufficiency fractures of the female pelvis: evaluation with MR imaging.
• Intrapleural streptokinase for the treatment of childhood empyema.
• MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4).
• MOSQUITOES OF TAIWAN: GENUS TOXORHYNCHITES THEOBALD.
• Natural products and their derivatives as cancer chemopreventive agents.
• Outcome of large hemispheric infarcts: an experience of 50 patients in Taiwan.
• Phenotypic Characteristics of Bone in Carbonic Anhydrase II-Deficient Mice.
• Prochlorperazine and chlorpromazine: a comparative clinical trial.
• Purine analogs as CDK enzyme inhibitory agents: a survey and QSAR analysis.
• Regional versus general anesthesia for hip surgery in older patients: does the choice affect patient outcome?
• Ribonucleotide reductase inhibitors as anticancer and antiviral agents.
• Structures, properties and disposition of drugs.
• Unexpected Severe LVH in the Elderly: Consider Fabry's Disease.
• [CARDIOVASCULAR DISEASES IN TAIWAN.]
• [CARDIOVASCULAR DISEASES IN TAIWAN.]